ClearBridge Investments’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.3M | Buy |
1,027,527
+49,460
| +5% | +$2.52M | 0.04% | 308 |
|
|
2025
Q1 | $44.1M | Buy |
978,067
+70,750
| +8% | +$3.19M | 0.04% | 326 |
|
|
2024
Q4 | $37.5M | Buy |
907,317
+18,217
| +2% | +$753K | 0.03% | 353 |
|
|
2024
Q3 | $34.7M | Buy |
889,100
+189,167
| +27% | +$7.38M | 0.03% | 378 |
|
|
2024
Q2 | $23.9M | Buy |
699,933
+436,349
| +166% | +$14.9M | 0.02% | 426 |
|
|
2024
Q1 | $6.62M | Sell |
263,584
-513
| -0.2% | -$12.9K | 0.01% | 574 |
|
|
2023
Q4 | $7.8M | Buy |
264,097
+247,933
| +1,534% | +$7.32M | 0.01% | 558 |
|
|
2023
Q3 | $511K | Sell |
16,164
-4,400
| -21% | -$139K | ﹤0.01% | 650 |
|
|
2023
Q2 | $532K | Sell |
20,564
-30,381
| -60% | -$786K | ﹤0.01% | 663 |
|
|
2023
Q1 | $1.22M | Buy |
50,945
+19,790
| +64% | +$475K | ﹤0.01% | 636 |
|
|
2022
Q4 | $608K | Buy |
31,155
+10,470
| +51% | +$204K | ﹤0.01% | 693 |
|
|
2022
Q3 | $435K | Sell |
20,685
-12
| -0.1% | -$252 | ﹤0.01% | 699 |
|
|
2022
Q2 | $403K | Hold |
20,697
| – | – | ﹤0.01% | 725 |
|
|
2022
Q1 | $456K | Buy |
+20,697
| New | +$456K | ﹤0.01% | 736 |
|